Wave Life Sciences, Inc. (WVE) stock
WVENasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 27, 2026Score 10/3046% below fair value
$2.77−0.07 (-2.46%)
Close on Nov 18, 2026Market cap $546.32MP/E –Yield –
Wave Life Sciences total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
No total debt figures for Wave Life Sciences
Wave Life Sciences has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?